Avax Techs Stock Today
Performance0 of 100
| Odds Of DistressLess than 37
|
Avax Techs has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Avax Techs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of December 1996 | Category Healthcare | Classification Health Care |
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania. Avax Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. More on Avax Techs
Moving against Avax Stock
Avax Techs cannot be verified against its exchange. It appears that Avax Techs is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshAvax Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Avax Techs (AVXT) is traded on OTCCE Exchange in USA and employs 9 people. Avax Techs is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.42 M. Avax Techs conducts business under Biotechnology sector and is part of Health Care industry.
Avax Techs currently holds about 86.4 K in cash with (3.44 M) of positive cash flow from operations.
Check Avax Techs Probability Of Bankruptcy
Avax Stock Against Markets
Try Other Suggestions
Already Invested in Avax Techs?
The danger of trading Avax Techs is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avax Techs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avax Techs. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avax Techs is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Avax Stock Analysis
When running Avax Techs' price analysis, check to measure Avax Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avax Techs is operating at the current time. Most of Avax Techs' value examination focuses on studying past and present price action to predict the probability of Avax Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avax Techs' price. Additionally, you may evaluate how the addition of Avax Techs to your portfolios can decrease your overall portfolio volatility.